ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,794, issued on Jan. 20, was assigned to BAHCESEHIR UNIVERSITESI (Istanbul), ISTANBUL TEKNIK UNIVERSITESI (Istanbul), AGRI IBRAHIM CECEN UNIVERSITESI STRATEJI DAIRE BASK. (Agri, Turkey) and ISTANBUL GEDIK UNIVERSITESI (Istanbul).
"MAO-B inhibitor DRG-MAOB-1 for use in treatment of neurodegenerative diseases" was invented by Serdar Durdagi (Istanbul), Mine Yurtsever (Istanbul), Busecan Aksoydan (Istanbul), Yusuf Serhat Is (Istanbul) and Murat Senturk (Istanbul).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MAO-B....